Introduction and Objective: Sustainable quality improvement in diabetes care remains challenging in resource-constrained health systems, where time and staffing often limit feasibility. This study evaluated whether a minimally time-consuming, continuously applied monitoring approach could support sustained glycemic improvement and guide data-informed interventions in a rural diabetes education program.Methods: Retrospective pre-post analyses were conducted on monthly […]
Read MoreMonth: June 2026
1341-OR: Freestyle Libre Use Associated with Faster Time to Glycemic Target in People with Diabetes Not Treated with Insulin
Introduction and Objective: Timely glycemic control reduces the risk of diabetes complications. This study evaluated whether initiating FreeStyle Libre (FSL) was associated with faster achievement of A1C targets (6.5%, 7%, and 8%) than no continuous glucose monitoring (CGM) in non-insulin treated adults with type 2 diabetes (NIT2D).Methods: Using Truveta electronic health record data, adults (≥ […]
Read More
First Vaccine Designed by AI Safely Tested on Humans
Share on PinterestA new vaccine designed by AI is the first to be tested on humans and may protect against a wide range of coronaviruses related to SARS and COVID-19. miodrag ignjatovic/GettyImages Researchers have tested a vaccine designed to protect against a range of coronaviruses. This new vaccine was the first designed by AI to […]
Read More1333-OR: Metformin Exposure In Utero Remodels Fetal Hepatic Mitochondrial Oxidation Capacity and Produces Early MASLD Hallmarks
Introduction and Objective: Metformin taken during pregnancy crosses the placenta. In vitro, it has robust metabolic stress effects in fetal hepatocytes. We hypothesized that metformin exposure in utero would disrupt oxidative metabolism and produce hepatocellular injury in the fetal liver, a major site of uptake.Methods: Pregnant Rhesus macaques received vehicle (VEH), or metformin (MET) and […]
Read More1304-OR: Diabetes Community Health Worker Improves Glycemic Control for Complex Patients in Urban Enhanced Primary Care Model
Introduction and Objective: Despite benefits of modern diabetes (DM) care, population-level glycemic control has not improved, especially among groups often marginalized from traditional care due to socioeconomic and cultural factors.Methods: The DICHA (DM In Control for Hispanics through an Alliance) program is a 6-month enhanced primary care model for Latino people with diabetes (LPWD) that […]
Read More
What Is the ‘New’ FDA Approved Sunscreen Ingredient?
Share on PinterestBemotrizinol (PARSOL Shield), an advanced sunscreen filter that has long been used in Europe and Asia, has been approved for use in the U.S. by the FDA. Image Credit: Photo by LumiNola/Getty Images The FDA has approved bemotrizinol (PARSOL Shield). This is the first new sunscreen ingredient approved in over 20 years, offering […]
Read More1313-OR: Harmine Engages Two Distinct Signaling Pathways in Human β-Cells: DYRK1A-Driven Proliferation and PKA-Mediated Differentiation and Function
Introduction and Objective: Small-molecule DYRK1A inhibitors such as harmine stimulate adult human β-cell proliferation; however, only a subset enhances β-cell identity/function. We sought to define the signaling mechanism underlying this phenotype, determine whether it is a class effect or requires DYRK1A inhibition, and identify the responsible pathway in human β-cells.Methods: Primary human islets and R7T1 […]
Read More1294-OR: Efruxifermin Improved Liver Disease and Insulin Sensitivity in Participants with Type 2 Diabetes and Metabolic Dysfunction–Associated Steatohepatitis (MASH) Cirrhosis in the SYMMETRY Trial
Introduction and Objective: T2D increases the risk of clinical outcomes in MASH cirrhosis. This post hoc analysis assessed changes in liver disease and insulin sensitivity in participants with baseline T2D and compensated cirrhosis due to MASH in the SYMMETRY trial of efruxifermin.Methods: SYMMETRY (NCT05039450) is a phase 2b, randomized, placebo-controlled trial that evaluated efruxifermin QW […]
Read More1287-OR: Dyadic Coping and Data Sharing among Older Adults with Type 1 Diabetes: A Qualitative Analysis of the Share Plus Intervention
Introduction and Objective: Older adults with type 1 diabetes face age-related changes. Dyadic coping, where care partners (CPs) and people with diabetes (PWD) collaboratively manage diabetes, can improve outcomes but is hindered by misaligned illness appraisals (viewing diabetes as individual vs. shared responsibility) and communication difficulties. This study describes experiences of older PWD/CP dyads in […]
Read More1281-OR: Risk of Myocardial Infarction (MI) and Ischemic Stroke (IS) following Herpes Zoster (HZ) in Older Adults with T2DM in the U.S.
Introduction and Objective: HZ has been associated with a higher risk of cardiovascular events, but evidence in T2DM is limited. This analysis assessed associations between HZ and MI/IS in older adults with T2DM.Methods: Using US administrative claims and EHR data (Optum Market Clarity, 2016-2024), adults with T2DM and HZ were identified by ICD-10 diagnosis codes. […]
Read More